HKD18.82
0.16% today
Hong Kong, Sep 17, 10:00 am CET
ISIN
CNE100000FN7
Symbol
1099
Index

Sinopharm Group Stock price

HKD18.79
-0.57 2.94% 1M
-0.87 4.43% 6M
-2.51 11.78% YTD
+2.05 12.25% 1Y
+2.85 17.88% 3Y
+0.39 2.12% 5Y
-9.36 33.25% 10Y
+0.23 1.24% 20Y
Hong Kong, Closing price Tue, Sep 16 2025
-0.16 0.84%
ISIN
CNE100000FN7
Symbol
1099
Index

Key metrics

Basic
Market capitalization
HKD59.1b
Enterprise Value
HKD83.2b
Net debt
HKD24.1b
Cash
HKD59.4b
Shares outstanding
3.1b
Valuation (TTM | estimate)
P/E
7.6 | 6.7
P/S
0.1 | 0.1
EV/Sales
0.1 | 0.1
EV/FCF
7.9
P/B
0.7
Dividends
DPS
HKD0.74
Yield 1Y | 5Y
3.9% | 4.3%
Growth 1Y | 5Y
-22.7% | 2.5%
Payout 1Y | 3Y
29.9% | 30.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HKD639.3b | HKD662.1b
EBITDA
HKD24.6b | HKD23.3b
EBIT
HKD19.4b | HKD19.5b
Net Income
HKD7.7b | HKD8.7b
Free Cash Flow
HKD10.5b
Growth (TTM | estimate)
Revenue
-2.0% | 3.6%
EBITDA
-15.7% | 8.6%
EBIT
-20.2% | 0.1%
Net Income
-22.1% | 12.9%
Free Cash Flow
-35.5%
Margin (TTM | estimate)
Gross
7.6%
EBITDA
3.9% | 3.5%
EBIT
3.0%
Net
1.2% | 1.3%
Free Cash Flow
1.6%
Financial Health
Equity Ratio
20.1%
Return on Equity
8.9%
ROCE
12.5%
ROIC
7.4%
Debt/Equity
1.0
More
EPS
HKD2.5
FCF per Share
HKD3.4
Short interest
-
Employees
108k
Rev per Employee
HKD5.9m
Show more

Is Sinopharm Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,016 stocks worldwide.

Sinopharm Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Sinopharm Group forecast:

15x Buy
68%
6x Hold
27%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Sinopharm Group forecast:

Buy
68%
Hold
27%
Sell
5%

Financial data from Sinopharm Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
639,269 639,269
2% 2%
100%
- Direct Costs 590,867 590,867
1% 1%
92%
48,402 48,402
9% 9%
8%
- Selling and Administrative Expenses 29,479 29,479
1% 1%
5%
- Research and Development Expense - -
-
-
24,613 24,613
16% 16%
4%
- Depreciation and Amortization 5,177 5,177
7% 7%
1%
EBIT (Operating Income) EBIT 19,435 19,435
20% 20%
3%
Net Profit 7,710 7,710
22% 22%
1%

In millions HKD.

Don't miss a Thing! We will send you all news about Sinopharm Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Head office China
Employees 108,217
Founded 2003
Website www.sinopharmgroup.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today